Drug Database
PR

pregabalin (Lyrica OD)

✓ Approved

Eisai Co., Ltd. · CACNA2D1 · Small Molecule

What is pregabalin?

pregabalin is a small molecule developed by Eisai Co., Ltd.. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesLyrica OD
CompanyEisai Co., Ltd.
Drug ClassSmall Molecule
Molecular TargetCACNA2D1
RouteOral (PO)
StatusApproved

Mechanism of Action

Molecular Targets

pregabalin acts on 1 molecular target:

CACNA2D1calcium voltage-gated channel auxiliary subunit alpha2delta 1 (LINC01112, CACNA2)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

pregabalin is developed for 3 unique indications across 2 therapeutic areas.

Therapeutic AreaConditionPhase
Musculoskeletal and connective tissue disordersFibromyalgia✓ Approved
Nervous system disordersDiabetic neuropathyPreclinical
Nervous system disordersPost herpetic neuralgiaPreclinical

Related Research Articles

PubMedPsychopharmacology bulletin2026-09-20

Gabapentin-Induced Severe Vivid Nightmares: A Case Series and Brief Review.

Hasoon Jamal J, Nguyen Anvinh A, Safabakhsh Negaar Ada NA, Viswanath Omar O et al.

Gabapentin is widely prescribed for neuropathic and radicular pain syndromes. While somnolence and dizziness are well-recognized adverse effects, severe vivid nightmares may constitute an underreported psychiatric side effect that can significantly impair quality of life and treatment adherence. We present two cases of gabapentin-induced severe vivid nightmares in patients treated for spinal pain syndromes. Management strategies included medication discontinuation and transition to pregabalin. Both patients experienced resolution of nightmares following intervention. This report reviews the existing literature on gabapentin's effects on sleep architecture and discusses potential mechanisms, clinical implications, and management approaches.

PubMedIDCases2026-09-20

Therapeutic drug monitoring uncovering incorrect antiretroviral drug intake in a patient with swallowing difficulties.

Carrozzo Giorgia G, Cattaneo Dario D, Giacomelli Andrea A, Gori Andrea A et al.

A woman living with HIV reported swallowing difficulties that interfered with oral antiretroviral therapy. Treatment with darunavir/cobicistat/emtricitabine/tenofovir alafenamide (Symtuza®) was initiated, with the patient choosing to chew the tablet before swallowing because of her swallowing difficulties. Therapeutic drug monitoring, performed because of this non-standard administration, revealed unexpectedly low darunavir trough concentrations despite reported adherence and maintained virological suppression. A structured pharmacological assessment revealed that the patient had been consistently taking the medication in the fasting state, despite initial counselling to take it with food. After correction of the drug intake conditions, darunavir exposure increased to therapeutic levels. This case highlights the clinical value of therapeutic drug monitoring in identifying medication intake errors and optimising antiretroviral therapy in patients with swallowing difficulties.

PubMedIranian journal of pharmaceutical research : IJPR2026-09-20

Evaluation of the Protective Effect of a Well-Characterized n-Hexane Extract of Black Soldier Fly Larvae (Hermetia illucens) Against Acrylamide-Induced Testicular Damage in Male Rats: A Histopathological, Oxidative Stress, Inflammatory, and Molecular Study.

Heidari Fateme F, Zarei Taher Tahereh T, Arast Yalda Y

Acrylamide (ACR) is a ubiquitous contaminant present in environmental and dietary sources and is formed particularly in starchy foods during high-temperature processing. Prolonged exposure to ACR is associated with testicular dysfunction mediated by oxidative injury, inflammatory responses, and apoptotic cell death. Black soldier fly larvae (BSFL; Hermetia illucens) represent a sustainable source of bioactive lipids, notably lauric acid, which has recognized antioxidant and anti-inflammatory properties. Importantly, BSFL can be cultivated on organic waste, converting low-value materials into lipid-enriched biomass with therapeutic potential, consistent with the principles of the circular economy. This study was designed, for the first time, to investigate the protective potential of a chemically characterized n-hexane extract of BSFL against acrylamide-induced testicular toxicity in a rat model. Thirty-five adult male Wistar rats were allocated to five experimental groups (n = 7 per group): vehicle control, ACR (20 mg/kg), ACR plus BSFL180 (180 mg/kg), ACR plus BSFL360 (360 mg/kg), and BSFL360 alone. All treatments were administered orally for 28 consecutive days. Serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and dihydrotestosterone (DHT) were measured. Testicular specimens were analyzed for oxidative stress markers (malondialdehyde [MDA], superoxide dismutase [SOD], catalase [CAT], glutathione peroxidase [GPx], reduced glutathione [GSH]), inflammatory cytokines (TNF-α, IL-6, IL-1β), and apoptosis-related proteins (Nrf2, Bcl-2, Bax). Histological assessment was performed using H&E staining. ACR administration markedly reduced serum FSH, LH, and DHT levels; increased MDA and pro-inflammatory cytokine levels; suppressed antioxidant enzyme activities and GSH content; and induced severe histopathological damage. Co-administration of BSFL extract, particularly at 360 mg/kg, dose-dependently counteracted these detrimental effects. Western blot analysis showed that BSFL extract upregulated Nrf2 and Bcl-2 expression while downregulating Bax, thereby restoring the Bax/Bcl-2 balance. The extract alone produced no adverse effects. The n-hexane extract of BSFL exerts substantial protective effects against ACR-induced testicular toxicity by restoring hormonal balance, mitigating oxidative stress, suppressing inflammation, and modulating Nrf2 and Bax/Bcl-2 signaling. These findings highlight the therapeutic potential of BSFL as a sustainable, cost-effective natural product within a circular bioeconomy framework and a novel approach to preventing chemically induced testicular injury.

PubMedJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia2026-09-19

Letter to the Editors on "Analysis of the effects of combined electrical spinal cord stimulation and pregabalin therapy in patients with herpes zoster trigeminal neuralgia" by Jiang et al.

Vannemreddy Prasad S PS, Bahrii Romana V RV, Slavin Konstantin V KV

PubMedFrontiers in microbiology2026-09-19

Orally ingested Lactobacillus crispatus VPC177 enhances total vaginal Lactobacillus counts-a cross-over exploratory study.

Berggren Anna A, Farrell Mary M, Sun Li L, Neilands Jessica J

The vaginal microbiome plays a crucial role in vaginal health, and disturbances in the microbial balance can negatively affect female wellbeing. In recent years, there has been growing interest in the use of probiotics and prebiotics to support a healthy vaginal microbiota. However, effects are often strain-specific and should be clinically demonstrated to influence the vaginal microbiota. This study aimed at evaluating the ability of four different orally administered probiotic strains to affect the fecal, and more specifically, the vaginal microbiota in healthy women. In this open-label, cross-over, exploratory study 35 women age 20-63 years consumed four different strains, Lactobacillus crispatus VPC111, Lactobacillus gasseri VPG44, L. crispatus VPC177 and Lactiplantibacillus plantarum HEAL9® for 14 days each with a washout period of 14 days between each intervention period. Levels of lactobacilli were assessed in fecal and vaginal samples following each intervention period. VPC111, VPC177, and HEAL9 all resulted in significant increases in fecal lactobacilli after 14 days intervention compared to baseline (p < 0.05). VPC177 significantly increased vaginal lactobacilli (p = 0.001), whereas VPC111, VPG44, and HEAL9 showed no significant vaginal effects. Post hoc characterization of L. crispatus VPC177 demonstrated that it produces both D- and L-lactate at high levels (9.31 and 4.58 g/L, respectively) and possesses genes associated with bacteriocin production, glycogen utilization, and mucosal adhesion, supporting its potential for antimicrobial activity, carbohydrate metabolism, and colonization of the vaginal environment. These findings demonstrate that probiotic effects on the vaginal microbiota are strain-specific, and that an increase in fecal lactobacilli does not necessarily translate into corresponding changes in the vaginal microbial community. Among the strains evaluated, VPC177 was the most promising candidate for supporting vaginal health through oral probiotic administration.

PubMedAnalytica chimica acta2026-09-19

Portable 3D-printed system for on-site MDMA electrochemical detection.

Bottelli Elisa D ED, Melo Larissa M A LMA, Bridges Maxwell D MD, Boes Jason J et al.

MDMA (3,4-methylenedioxymethamphetamine), also known as "ecstasy", is a widely used stimulant and hallucinogenic drug. Its popularity in recreational settings is attributed to its euphoric effects; however, MDMA consumption is associated with health risks. The global increase in synthetic drug consumption highlights the urgent need for rapid, cost-effective, and portable detection systems for on-site analysis. In this study, a simple, sensitive, and portable 3D-printed electrochemical system was developed for on-site quantitative and qualitative detection of MDMA. The electrode surface was first sanded to partially remove the insulating polylactic acid (PLA) layer and subsequently irradiated with a CO2 laser to expose conductive carbon regions. Morphological characterizations confirmed surface modification, while electrochemical studies revealed a significant improvement in electrochemical performance after treatment. The reagent-free treatment enabled sensitive MDMA detection using differential pulse voltammetry (DPV), with a linear response in the concentration range of 2.5 to 100 μmol L-1 MDMA and limits of detection (LOD) and quantification (LOQ) of 0.080 and 0.27 μmol L-1 MDMA, respectively. The electrodes exhibited good reproducibility (RSD = 5.50%, n = 5) and stability, with only a 13% decrease in peak current after 28 days of storage. The sensor was also successfully applied to detect MDMA in seized tablet samples. With minimal sample consumption (100 μL), low waste generation, and a low production cost (≈US$0.18 per device), the system supports a one-sensor-per-analysis approach that can be easily operated by a non-electrochemist analyst. Compact and smartphone-compatible, the device represents a promising, low-cost, on-site-deployable alternative for rapid MDMA screening in forensic and law enforcement applications.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about pregabalin